Literature DB >> 10906834

The pathology of median neuropathy in acromegaly.

P J Jenkins1, S A Sohaib, S Akker, R R Phillips, K Spillane, J A Wass, J P Monson, A B Grossman, G M Besser, R H Reznek.   

Abstract

BACKGROUND: Median neuropathy is commonly associated with acromegaly, although its pathology is uncertain.
OBJECTIVE: To study the pathology of median neuropathy in acromegaly by using magnetic resonance imaging (MRI).
DESIGN: Case series. SETTINGS: Outpatient clinic and MRI unit. PATIENTS: Nine patients with acromegaly, four of whom had clinical symptoms of neuropathy. MEASUREMENTS: At presentation and 6 months after treatment, median nerve size, its signal intensity, and the volume of the carpal tunnel contents were measured.
RESULTS: At presentation, patients with symptoms of neuropathy had increased nerve size and signal intensity compared with asymptomatic patients, but the two groups did not differ in volume of carpal tunnel contents. These measures improved with treatment of acromegaly in symptomatic patients; asymptomatic patients experienced no change or worsening.
CONCLUSION: The predominant pathology of median neuropathy in acromegaly seems to be increased edema of the median nerve within the carpal tunnel rather than extrinsic compression from increased volume of the carpal tunnel contents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906834     DOI: 10.7326/0003-4819-133-3-200008010-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

Review 1.  Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations.

Authors:  A Tagliafico; E Resmini; D Ferone; C Martinoli
Journal:  Radiol Med       Date:  2011-03-19       Impact factor: 3.469

Review 2.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

3.  Median nerve conduction studies and wrist magnetic resonance imaging in acromegalic patients with carpal tunnel syndrome.

Authors:  Yasuo Sasagawa; Osamu Tachibana; Mariko Doai; Hisao Tonami; Hideaki Iizuka
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

Review 4.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

5.  Carpal tunnel syndrome as an occupational disease by Dr. med. Klaus Giersiepen und Dr. med. Michael Spallek in volume 14/2011. Recognize acromegaly.

Authors:  Matthias Breidert
Journal:  Dtsch Arztebl Int       Date:  2011-06-17       Impact factor: 5.594

6.  Peripheral nervous system assessment in acromegaly patients under somatostatin analogue therapy.

Authors:  H Alibas; D Gogas Yavuz; P Kahraman Koytak; M Uygur; T Tanridag; K Uluc
Journal:  J Endocrinol Invest       Date:  2016-08-02       Impact factor: 4.256

Review 7.  Rheumatic manifestations of pituitary tumors.

Authors:  S Stavrou; D L Kleinberg
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

8.  The problem of unrecognized acromegaly: surgeries patients undergo prior to diagnosis of acromegaly.

Authors:  F E Keskin; D O Yetkin; H M Ozkaya; O Haliloglu; S Sadri; N Gazioglu; N Tanrıover; H Ak; E Hatipoglu; P Kadıoglu
Journal:  J Endocrinol Invest       Date:  2015-02-26       Impact factor: 4.256

Review 9.  Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.

Authors:  A Giustina; A Barkan; P Chanson; A Grossman; A Hoffman; E Ghigo; F Casanueva; A Colao; S Lamberts; M Sheppard; S Melmed
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

10.  Diagnosis and treatment of acromegaly complications.

Authors:  A Giustina; F F Casanueva; F Cavagnini; P Chanson; D Clemmons; L A Frohman; R Gaillard; K Ho; P Jaquet; D L Kleinberg; S W J Lamberts; G Lombardi; M Sheppard; C J Strasburger; M L Vance; J A H Wass; S Melmed
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.